Zoetis (ZTS) Protective Put Calculator
Calculator · free · no signup · ZTSPrice a protective put, zero-cost collar, or put spread on Zoetis. Annual cost, max loss, upside cap, tax treatment, auto-filled from current ZTS option chain.
AlphaLatitude Inc. · Free ToolsOur tools respect your browsing privacy. Independently verified:
You priced one hedge. The beta picks the right hedge structure given your full equity stack and tax situation.
Request beta access →Related calculators: Stock Concentration Calculator
About Zoetis
Zoetis (ZTS) is a public Pharma/Biotech company, headquartered in Parsippany, NJ.
Last close: $69.69 per share (as of 2026-10-04).
Equity grants at Zoetis typically include restricted stock units (RSUs).
Zoetis Inc. (/zō-EH-tis/), headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
Source: Wikipedia (CC BY-SA 4.0)
Pfizer separated its animal-health division in 2013, creating the largest company dedicated to medicines and vaccines for pets and livestock. The two halves behave differently: companion-animal products are bought by owners treating pets as family and support premium pricing, while livestock products are an input cost farmers optimize. Veterinary approvals are cheaper and faster than human drug approvals, which changes the economics of developing a product. Dermatology and pain treatments for dogs have been the growth franchise. Headquarters are in Parsippany, New Jersey.
Sources: sec.gov · en.wikipedia.org
Equity comp at Zoetis
- Zoetis uses double trigger change in control protection: unvested RSUs and stock options accelerate only if the equity holder is involuntarily terminated without cause, or resigns for good reason, within a defined window (up to 24 months) after a change in control. A change in control alone does not vest awards.
- RSUs use double-trigger vesting. Two things must both happen before the shares are yours: (1) the normal time-based vesting completes, and (2) the company has a liquidity event (an IPO or an acquisition). Until both happen, you do not yet own the shares and you do not owe tax on them.
Researched 2026-08-27.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Zoetis.
A protective put caps your downside on the ZTS position at a chosen floor; a zero-cost collar pays for that floor by capping the upside. This calculator prices both structures off the current ZTS option chain, with annual cost, max loss, and tax-treatment notes.
Example: a 5,000-share ZTS position at $69.69 is worth $348,450. A 1-year 30%-OTM put on that position typically runs 2-4% of position value per year (about $6,969 to $13,938) before any premium offset from a short call. The calculator prices both structures off ZTS's current option chain so you see the actual cost for your chosen floor, tenor, and cap.
All Zoetis tools → · Use the generic Protect Your Stock Calculator for any company.
Zoetis equity questions
- How much does it cost to hedge ZTS stock?
- The cost of a protective put depends on how far below the current price you set the floor, how long the protection lasts, and ZTS's option-implied volatility. A zero-cost collar lowers that cost by selling away some upside. The calculator above prices both structures off the current ZTS option chain and shows the annual cost, maximum loss, and tax treatment.
- Does Zoetis grant ISOs, NSOs, or RSUs?
- Equity compensation at Zoetis typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
- Do Zoetis RSUs use double-trigger vesting?
- Yes. Zoetis restricted stock units (RSUs) vest only when two things both happen: the time-based schedule completes, and the company has a liquidity event such as an initial public offering (IPO) or an acquisition. Until both occur you do not own the shares and owe no tax on them.
Find another companyPharma/Biotech peers
One piece of the puzzle.
OptionsAhoy plans your Zoetis equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.